Literature DB >> 3871700

The action of human C3 in soluble or cross-linked form with resting and activated murine B lymphocytes.

A Erdei, F Melchers, T Schulz, M Dierich.   

Abstract

The third component of complement C3 has been implied in the stimulation of B lymphocytes to proliferation and maturation for Ig secretion. We have reinvestigated the extent of this activation with either activated or resting murine splenic lymphocytes in serum-substituted cultures. Human C3 was used in either soluble or cross-linked form. Soluble as well as Sepharose-bound or glutaraldehyde-cross-linked C3, over a range of concentrations, was inactive with resting splenic lymphocytes of (C57BL/6J X DBA/2)F1, C3H/HeJ and C57BL/6J nu/nu mice. However, lipopolysaccharide-activated spleen cells, enriched for B cell blasts, were stimulated by immobilized and cross-linked C3, while they did not respond to soluble C3. The extent of restimulation was comparable to that induced by lipopolysaccharide and resulted in both increased proliferation and maturation to Ig-secreting cells. The stimulation of the blast cells appears to be C3 specific, since it can be inhibited by free C3.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3871700     DOI: 10.1002/eji.1830150214

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  15 in total

Review 1.  Functional B-lymphocyte surface antigens.

Authors:  J T Golay
Journal:  Immunology       Date:  1986-09       Impact factor: 7.397

2.  Synergistic activation of cells by Epstein-Barr virus and B-cell growth factor.

Authors:  L M Hutt-Fletcher
Journal:  J Virol       Date:  1987-03       Impact factor: 5.103

3.  Structural and functional analysis of CR2/EBV receptor by means of monoclonal antibodies and limited tryptic digestion.

Authors:  A L Petzer; T F Schulz; R Stauder; A Eigentler; B L Myones; M P Dierich
Journal:  Immunology       Date:  1988-01       Impact factor: 7.397

Review 4.  Surface antigens associated with human B cell activation.

Authors:  L K Jung
Journal:  Immunol Res       Date:  1986       Impact factor: 2.829

5.  Determination of soluble CD21 as a parameter of B cell activation.

Authors:  H P Huemer; C Larcher; W M Prodinger; A L Petzer; M Mitterer; N Falser
Journal:  Clin Exp Immunol       Date:  1993-08       Impact factor: 4.330

6.  Secretion, cleavage and binding of complement component C3 by the human monocytic cell line U937.

Authors:  C M Maison; C L Villiers; M G Colomb
Journal:  Biochem J       Date:  1989-07-15       Impact factor: 3.857

7.  Chronic immune thrombocytopenic purpura--immunological analyses of a patient pre- and post-HIV seroconversion.

Authors:  P J Späth; A Elisa; U Bühlmann; L Luginbühl; P Imbach
Journal:  Blut       Date:  1989-07

8.  Receptors for the third component of complement: their association with maturation stage in non-Hodgkin lymphomas (NHL) and their possible implication with the development of follicular structures.

Authors:  R Greil; C Gattringer; T Schulz; W Knapp; T Radaskiewicz; M P Dierich; H Huber
Journal:  Clin Exp Immunol       Date:  1986-05       Impact factor: 4.330

9.  The structure of an alternate form of complement C3 that displays costimulatory growth factor activity for B lymphocytes.

Authors:  Y Cahen-Kramer; I L Mårtensson; F Melchers
Journal:  J Exp Med       Date:  1994-12-01       Impact factor: 14.307

10.  Follicular dendritic cells help resting B cells to become effective antigen-presenting cells: induction of B7/BB1 and upregulation of major histocompatibility complex class II molecules.

Authors:  M H Kosco-Vilbois; D Gray; D Scheidegger; M Julius
Journal:  J Exp Med       Date:  1993-12-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.